Dr. Amitabha Mazumder
Claim this profileThe Oncology Institute of Hope and Innovation
Area of expertise
Relapse
Amitabha Mazumder has run 3 trials for Relapse. Some of their research focus areas include:
Multiple Myeloma
Amitabha Mazumder has run 2 trials for Multiple Myeloma.
Affiliated Hospitals
The Oncology Institute Of Hope And Innovation
Oncology Institute Of Hope And Innovation
Clinical Trials Amitabha Mazumder is currently running
Mezigdomide + Carfilzomib + Dexamethasone
for Multiple Myeloma
This trial is testing a new drug called Mezigdomide combined with two other drugs to treat patients whose blood cancer has come back or not responded to previous treatments. The new drug aims to stop cancer cells from growing and spreading.
Recruiting
2 awards
Phase 3
Selinexor + R-GDP
for Lymphoma
The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive hematopoetic stem cell transplantation (HSCT) or chimeric antigen receptor T cell (CAR-T) therapy. This study consists of 3 arms each in Phase 2 and 3. Phase 2 portion of the study will assess the two doses of selinexor (40 milligram \[mg\] or 60 mg) in combination with R-GDP, for up to 6 cycles (21-day per cycle), followed by 60 mg selinexor single agent continuous therapy for those who have reached a partial or complete response. Phase 3 portion of the study will evaluate the selected dose of SR-GDP (identified in Phase 2) versus standard R-GDP + matching placebo, for up to 6 cycles (21-day per cycle), followed by placebo or 60 mg selinexor single agent continuous therapy for those who have reached partial or complete response.
Recruiting
0 awards
Phase 2 & 3
9 criteria
More about Amitabha Mazumder
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Amitabha Mazumder has experience with
- Selinexor
- Dexamethasone
- Rituximab
- Pembrolizumab
- KPT-8602
- HBI-2438
Breakdown of trials Amitabha Mazumder has run
Relapse
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amitabha Mazumder specialize in?
Amitabha Mazumder focuses on Relapse and Multiple Myeloma. In particular, much of their work with Relapse has involved MYC positive patients, or patients who are Bcl2 positive.
Is Amitabha Mazumder currently recruiting for clinical trials?
Yes, Amitabha Mazumder is currently recruiting for 2 clinical trials in Pasadena California. If you're interested in participating, you should apply.
Are there any treatments that Amitabha Mazumder has studied deeply?
Yes, Amitabha Mazumder has studied treatments such as Selinexor, Dexamethasone, Rituximab.
What is the best way to schedule an appointment with Amitabha Mazumder?
Apply for one of the trials that Amitabha Mazumder is conducting.
What is the office address of Amitabha Mazumder?
The office of Amitabha Mazumder is located at: The Oncology Institute of Hope and Innovation, Pasadena, California 91105 United States. This is the address for their practice at the The Oncology Institute of Hope and Innovation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.